These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11763521)

  • 1. [Antioxidant and antiarrhythmic activity of carvedilol in patients with ischemic heart disease. Comparison with anaprilin].
    Vasil'ev AP; Strel'tsova NN; Gorbunova TIu; Mal'tseva IA; Zykova EL
    Ter Arkh; 2001; 73(10):65-7. PubMed ID: 11763521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial.
    McMurray J; Køber L; Robertson M; Dargie H; Colucci W; Lopez-Sendon J; Remme W; Sharpe DN; Ford I
    J Am Coll Cardiol; 2005 Feb; 45(4):525-30. PubMed ID: 15708698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does carvedilol have antiarrhythmic properties?
    Naccarelli GV
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):338-9. PubMed ID: 16265556
    [No Abstract]   [Full Text] [Related]  

  • 4. A critical review of the use of carvedilol in ischemic heart disease.
    Chen-Scarabelli C; Saravolatz L; Murad Y; Shieh WS; Qureshi W; Di Rezze J; Abrencillo R; Gardin T; Gidwani UK; Saravolatz L; Faggian G; Scarabelli TM
    Am J Cardiovasc Drugs; 2012 Dec; 12(6):391-401. PubMed ID: 23061698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and hemodynamic effects of anaprilin and carvedilol in patients with coronary heart disease].
    Vasil'ev AP; Strel'tsova NN; Gorbunova TIu; Dubova TV
    Klin Med (Mosk); 2001; 79(12):13-6. PubMed ID: 11840802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contribution of antioxidant properties of carvedilol in its effect on cardiac remodeling in patients with ischemic heart disease with incipient heart failure].
    Vasil'ev AP; Strel'tsova NN; Gorbunova TIu
    Kardiologiia; 2003; 43(2):69-70. PubMed ID: 12913988
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.
    Dargie HJ
    Lancet; 2001 May; 357(9266):1385-90. PubMed ID: 11356434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carvedilol.
    Crysant SG
    Arch Fam Med; 1999; 8(4):295. PubMed ID: 10418532
    [No Abstract]   [Full Text] [Related]  

  • 9. Carvedilol--clinical experience in arrhythmias.
    Storstein L
    Cardiology; 1993; 82 Suppl 3():29-33. PubMed ID: 8106161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of different beta-blockers on left-ventricular volume and function after primary coronary stenting in acute myocardial infarction.
    Lee SH; Yoon SB; Cho JR; Choi S; Jung JH; Lee N
    Angiology; 2008 Dec-2009 Jan; 59(6):676-81. PubMed ID: 18388053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Status of microcirculation and cardiodynamics in ischemic heart disease patients with decreased left ventricular fraction and their response to carvedilol].
    Vasil'ev AP; Strel'tsova NN; Gorbunova TIu
    Ter Arkh; 2002; 74(11):69-71. PubMed ID: 12498134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of carvedilol on ventricular arrhythmias.
    Senior R; Müller-Beckmann B; DasGupta P; van der Does R; Lahiri A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S117-21. PubMed ID: 1378137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carvedilol: a nonselective beta blocking agent with antioxidant properties.
    Book WM
    Congest Heart Fail; 2002; 8(3):173-7, 190. PubMed ID: 12045386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of carvedilol arrhythmia data in clinical trials.
    Kowey PR
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S59-68. PubMed ID: 15965573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol's antiarrhythmic properties: therapeutic implications in patients with left ventricular dysfunction.
    Naccarelli GV; Lukas MA
    Clin Cardiol; 2005 Apr; 28(4):165-73. PubMed ID: 15869048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
    Feuerstein GZ; Yue TL; Cheng HY; Ruffolo RR
    J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction].
    Kanopskiĭ SG; Staritskiĭ AG; Bozhko AA
    Kardiologiia; 2004; 44(10):13-8. PubMed ID: 15477784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy.
    Doughty RN; Whalley GA; Walsh HA; Gamble GD; López-Sendón J; Sharpe N;
    Circulation; 2004 Jan; 109(2):201-6. PubMed ID: 14707020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antianginal efficacy of carvedilol, a new beta-blocker with vasodilating action.
    Jamal SM; Freedman SB; Thomson A; Carter G; Harris PJ; Kelly DT
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S141-6. PubMed ID: 2454361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.